Patents/Inventors

John Desjarlais

Pasadena, CAUS21 patents

20 Patents

US125094952025
LAG-3 Targeted Heterodimeric Fusion Proteins Containing IL-15/IL-15RA Fc-fusion Proteins and LAG-3 Antigen Binding Domains
Xencor, Inc.
0 cites
US124158492025
Heterodimeric Proteins
Xencor, Inc.
0 cites
US123590022025
Heterodimeric Antibodies That Bind CD3 and Tumor Antigens
Xencor, Inc.
0 cites
US122396882025
IL-15/IL-15RA Heterodimeric Fc Fusion Proteins and Uses Thereof
Xencor, Inc.
0 cites
US121803022024
Heterodimeric Antibodies That Bind Fibroblast Activation Protein
Xencor, Inc.
0 cites
US121520762024
Bispecific and Monospecific Antibodies Using Novel Anti-pd-1 Sequences
Xencor, Inc.
0 cites
US121395252024
Targeted Heterodimeric Fc Fusion Proteins Containing IL-15 Il-15alpha and Antigen Binding Domains
Xencor, Inc.
0 cites
US121293092024
Heterodimeric Antibodies That Bind CD3 and CD38
Xencor, Inc.
0 cites
US119817172024
Engineered IL-2 Fc Fusion Proteins
Xencor, Inc.
0 cites
US119458802024
Heterodimeric Antibodies That Bind CD3 and Tumor Antigens
Xencor, Inc.
0 cites
US119326752024
PD-1 Targeted Il-15/il-15rα Fc Fusion Proteins with Improved Properties
XENCOR, Inc.
0 cites
US118590112024
Heterodimeric Antibodies That Bind CD3 and Tumor Antigens
Xencor, Inc.
0 cites
US118405792023
Bispecific Antibodies That Bind to CD38 and CD3
Xencor, Inc.
0 cites
US118208302023
Optimized Fc Variants
Xencor, Inc.
0 cites
US118144232023
Heterodimeric Proteins
Xencor, Inc.
0 cites
US117186672023
Optimized Antibody Variable Regions
Xencor, Inc.
0 cites
US116739722023
Heterodimeric Antibodies That Bind CD3 and Tumor Antigens
Xencor, Inc.
0 cites
US116345062023
Heterodimeric Proteins
Xencor, Inc.
0 cites
US116239572023
Heterodimeric Antibodies That Bind CD3 and PSMA
Xencor, Inc.
0 cites
US115847942023
Bispecific Heterodimeric Fusion Proteins Containing Il-15-il-15ralpha Fc-fusion Proteins and Immune Checkpoint Antibody Fragments
Xencor, Inc.
0 cites